Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight

20h ago, source: TMCnet

The increasing occurrence of kidney disorders worldwide and the healthcare sector's increased focus on consistent monitoring ...

Analysts Express Confidence in Alnylam's Hypertension Drug Despite Mixed Trial Data

on MSN ago, source:

Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) presented results from the KARDIA-2 Phase 2 study, which evaluated the efficacy ...

Alnylam Pharmaceuticals, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - ALNY

15d ago, source:

NEW YORK, NY / ACCESSWIRE / April 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Alnylam ...

Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise

9d ago, source:

PITTSBURGH, Pa., April 17, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company, today announced the expansion of ...

DelveInsight Business Research, LLP: Global Urine Output Monitoring Systems Market is Projected to Grow at a CAGR of ~5% by 2030 | DelveInsight

20h ago, source:

The increasing occurrence of kidney disorders worldwide and the healthcare sector's increased focus on consistent monitoring and effective management of these conditions are expected to drive ...